Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Dermata Therapeutics stock

Learn how to easily invest in Dermata Therapeutics stock.

Dermata Therapeutics is a biotechnology business based in the US. Dermata Therapeutics shares (DRMA) are listed on the NASDAQ and all prices are listed in US Dollars. Dermata Therapeutics employs 8 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Dermata Therapeutics stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – DRMA. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Dermata Therapeutics stock price (NASDAQ: DRMA)

Use our graph to track the performance of DRMA stocks over time.

Dermata Therapeutics shares at a glance

Information last updated 2023-01-26.
Latest market close$0.27
52-week range$0.16 - $2.45
50-day moving average $0.37
200-day moving average $0.63
Wall St. target price$6.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.85

Buy Dermata Therapeutics stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Dermata Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dermata Therapeutics price performance over time

Historical closes compared with the close of $0.2739 from 2023-01-31

1 week (2023-01-26) -4.23%
1 month (2022-12-30) -33.03%
3 months (2022-11-02) -57.86%
6 months (2022-08-02) -48.99%
1 year (2022-02-02) -87.66%
2 years (2021-02-02) -99.45%
3 years (2020-01-31) 50
5 years (2018-02-02) 50

Dermata Therapeutics financials

Gross profit TTM $0
Return on assets TTM -58.01%
Return on equity TTM -105.15%
Profit margin 0%
Book value $0.62
Market capitalisation $3.5 million

TTM: trailing 12 months

Dermata Therapeutics share dividends

We're not expecting Dermata Therapeutics to pay a dividend over the next 12 months.

You may also wish to consider:

Dermata Therapeutics overview

Dermata Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. The company was incorporated in 2014 and is headquartered in San Diego, California. .

Frequently asked questions

What percentage of Dermata Therapeutics is owned by insiders or institutions?
Currently 32.565% of Dermata Therapeutics shares are held by insiders and 1.601% by institutions.
How many people work for Dermata Therapeutics?
Latest data suggests 8 work at Dermata Therapeutics.
When does the fiscal year end for Dermata Therapeutics?
Dermata Therapeutics's fiscal year ends in December.
Where is Dermata Therapeutics based?
Dermata Therapeutics's address is: 3525 Del Mar Heights Road, San Diego, CA, United States, 92130
What is Dermata Therapeutics's ISIN number?
Dermata Therapeutics's international securities identification number is: US2498451085

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site